Alan B. Bennett
Associate Vice Chancellor for Research - Technology and Industry Alliances and professor of plant sciences at the University of California, Davis. Alan B. Bennett received his B.S. degree at the University of California, Davis in 1977 and Ph.D. at Cornell University in 1982, both in the field of plant biology. He joined the UC Davis faculty in 1983 where his research in plant molecular genetics has focused on cell wall disassembly and fruit development. He has given invited presentations at premier conferences, universities and research laboratories worldwide. Bennett served as Department Chair between 1990-1993 and Associate Dean of the College of Agricultural and Environmental Sciences from 1993-1999. He served as the Executive Director of the University of California Systemwide Office of Technology Transfer and Research Administration from 2000-2004, where he was responsible for intellectual property management in the University of California system. Bennett has a 50% appointment as Associate Vice Chancellor for Research effective July 2004 and his primary areas of responsibility are technology transfer, strengthening research-based alliances with industry, and supporting technology-based regional economic development. He is also the Founding Executive Director of the Public Intellectual Property Resource for Agriculture (PIPRA).
Dr. Carson is a noted researcher in the field of lymphoproliferative diseases. He developed the drug Cladribine, which is the treatment of choice for hairy cell leukemia marketed as Leustatin®.
He has played key roles in the founding of Vical, Inc., a gene therapy company, Dynavax Technologies, a biopharmaceutical company, Triangle Pharmaceuticals, an anti-virus company; and Salmedix, an anti-cancer company. Dr. Carson is Director of Rebecca and John Moores UCSD Cancer Center and has been a Professor in the Department of Medicine at the University of California, San Diego since 1990. He was elected to the National Academy of Science in 2003. Prior to joining UCSD, he was a Member in the Department of Molecular and Experimental Medicine at The Scripps Research Institute. He received his B.A. from Haverford College and M.D. from Columbia University.
Jia Chen is the Chief Operating Officer of the Institute for Cell Mimetic Space Exploration (CMISE) at UCLA. He oversees the general operations of CMISE and leads the technology transfer effort for the institute. Dr. Chen graduated from Cornell University in 2000, studying under Noel MacDonald's MEMS research program. After Cornell, Dr. Chen worked at Sarnoff Corporation for about four years, where he became a Technical Manager responsible for a team of researchers developing biomechanical products.
Bruce Hammock is a Professor of Entomology and in the UCDMC. He directs the NIEHS - UCD Superfund Basic Research Program and the NIH -UCD Biotechnology Training Grant. He a member of the US National Academy of Sciences and Founder and acting CSO of Arete Therapeutics of Davis.
Charles E. Hunt
Professor of Electrical and Computer Engineering
University of California, Davis
Charles E. Hunt received the B.S.E.E. and M.S.E.E. degree from the University of Utah and the Ph.D. degree in Electrical Engineering from Cornell University. From 1979 to 1983 he served as Staff Engineer to the VLSI Design Research Group at the Computer Science Department of the University of Utah,. Since 1986, he has been in the Electrical and Computer Engineering Department at the University of California at Davis, where is presently Professor, as well as a Staff Consultant for the Engineering Research Division of the Lawrence Livermore National Laboratory. He also holds the appointment of Visiting Professor of Electronics in the Faculty of Physics of the University of Barcelona. Professor Hunt teaches IC fabrication technology and semiconductor device physics. His research centers on microfabrication technology and design for electronic materials, electronic devices and circuits, and microstructures. His major research emphasis has been in the areas of field-emission vacuum microelectronics, semiconductor wafer bonding, silicon on insulator (SOI) materials and devices, and CVD epitaxy. Professor Hunt is a Senior Member of the Institute of Electrical and Electronics Engineers, and is Author or Co-Author of over one hundred refereed publications, eight books, and holds eleven patents. Since 1997 he has served as Editor of the journal, Solid-State Electronics. He has Chaired the International Vacuum Microelectronics Conference (2001), and has been Co-Organizer of the Electrochemical Society Symposia on Semiconductor Wafer Bonding.
Wendy S. Johnson
Senior Vice President Corporate Development, Salmedix
Wendy Johnson has broad experience in regulatory affairs, licensing, negotiation, establishment of international strategic alliances, acquisitions and various business relationships. Experienced with device, diagnostic and drug discovery and development, and regulatory affairs. Is known for intelligence, strong leadership capabilities, negotiation, managerial and communication skills. She joined Salmedix in April 2001 as Senior Vice President, Corporate Development. From July 1998 until July 2000 she served as Vice President, Business Development. From July 1994 until joining Women First, Ms. Johnson was Vice President, Corporate Development & Operations at Prizm Pharmaceuticals, currently Selective Genetics Incorporated. From July 1990 to June 1994, Ms. Johnson was Vice President, Business Development and Regulatory Affairs with Cytel Corporation. From June 1988 to June 1990, Ms. Johnson was with Symbiotics Corporation as Manager, Business Development. She worked for Murex Corporation, Cambridge U.K. as International Affairs Administrator from 1986 to 1988. From 1976 to 1986, Ms. Johnson served as Assistant Director with the Center for Devices and Radiological Health at the Food and Drug Administration. Ms. Johnson holds an M.B.A. from Loyola University, an M.S. in clinical microbiology from the Hahnemann Medical School and a B.S. in microbiology from the University of Maryland.
Goran Matijasevic is the Research Coordinator of the Integrated Nanosystems Research Facility at UC Irvine. He is working on development of new projects that involve industry and academia in the fields of RF/wireless and photonic communications, BioMEMS, and Nanotechnology. In this capacity, he works closely with industry partners on making them aware of the available university resources as well as how to establish collaborations with university researchers. Prior to UCI, he worked as a senior engineer and director of R&D at several start-up companies in the electronic materials and telecommunication area.
He has 4 U.S. patents, 3 book chapters, and over 40 publications and has served on the NEMI Industry Roadmap committee.
He served as NanoWorld Conference Chair and also the ECTC Conference Emerging Technologies Chair. He is currently on the Tech Tranfer Conference Organizing Committee as well as the OCTANe Steering Committee. Goran received his PhD from UC Irvine in Electrical and Computer Engineering in 1991 and his MBA from Pepperdine University in 2003. He is a member of Orange County Venture Group, Tech Coast Venture Network, Life Sciences Industry Council (LINC), IEEE, and ASME.
Managing Director, California, Seattle
ARCH Venture Partners
Biotechnology, Informatics, Medical Instrumentation, Pharmaceuticals
Scott Minick is a Managing
Director with ARCH, joining the firm as a Venture Partner in 1998.
Mr. Minick has been instrumental in the start-up, development and financing of several life sciences portfolio companies and currently serves as a board member at Achaogen, Amphora Discovery, FastTrack Systems, First Genetic Trust and MedVantx. He is also a board observer for Trubion Pharmaceuticals, Vascular Architects, and XenoPort. Mr. Minick formerly served as Chairman of Xcyte Therapies (XCYT) through its IPO in 2004 and as Executive Chairman of Amphora Discovery.
From 1995 until 1998, Mr.
Minick was director, President and Chief Operating Officer of SEQUUS Pharmaceuticals,
a fully integrated, public biopharmaceutical company. From 1994 to 1995, he
served as a director, President and CEO of OncoTherapeutics, a private biotechnology
company. Prior to that, Mr. Minick co-founded and was a director, President
and CEO of LXR Biotechnology from startup through its IPO. From 1981 to 1993,
he was an executive of Baxter Healthcare, holding leadership positions in device,
service and diagnostics businesses.
He received his postgraduate training in neurobiology at the Sale Institute, his M.B.A. from Northwestern University, and his B.A. with Honors from University of California at San Diego.
Lynn H. Pasahow
Lynn H. Pasahow is a partner and chair of the Litigation Group at Fenwick & West LLP. His practice focuses on patent and other intellectual property litigation, counseling, licensing, and mediation, principally relating to bioscience, software, and Internet technologies. Mr. Pasahow led the team that obtained a jury verdict upholding Cetus' patents on its Nobel Prize-winning polymerase chain reaction invention, and the team enforcing Amazon.com's 1-ClickŪ. Among his licensing projects is the University of California's prion-related portfolio resulting from the research of Dr. Stanley Prusiner's laboratory.
Mr. Pasahow's clients have
included Abbott, Amazon.com, American Express, Aradigm, Athena Neurosciences,
BDM International, Celera, Cepheid, Cetus, Chiron, Cognos, CooperVision, Cryptography
Research Inc., Eastman Kodak, Elan, First Data Corp., Genentech, Informatica,
Iomega, Large Scale Biology, Lockheed-Martin, NeXT, Pillar Point Partners, Quantum
Dot Corporation, Stanford University, T-Mobile USA, Topaz Technologies, University
of California, VIA Technologies, Vysis, Warner-Lambert and Xoma.
Mr. Pasahow is a director of the Bay Area Bioscience Center, the Alzheimer's Association of Northern California, and the Boalt Hall Alumni Association, and a member of the advisory board of the University of California's Berkeley Center for Law and Technology. He received his undergraduate degree from Stanford University in 1969 and his law degree from the University of California at Berkeley in 1972. Following graduation, he was a law clerk for the Honorable A.J. Zirpoli, United States District Court for the Northern District of California. He regularly lectures about intellectual property law subjects to groups that have included the Federal Judicial Center, American Association for the Advancement of Science, American Law Institute, Practicing Law Institute, Boalt School of Law and the University of California, San Francisco. He is among the intellectual property lawyers included in The Best Lawyers in America. Mr. Pasahow is a member of the state bar of California.
Albert P. Pisano
Albert ("Al") P. Pisano currently serves as Professor and Chair of the Department of Mechanical Engineering at the University of California at Berkeley, having been appointed to that position in 2004. He was elected to the National Academy of Engineering in 2001. Professor Pisano holds the FANUC Chair of Mechanical Systems in the Department of Mechanical Engineering, with a joint appointment to the Department of Electrical Engineering and Computer Science. He has previously served as Director of the Electronics Research Laboratory, the largest organized research unit on the UC Berkeley campus (with over $73 million in research funds each year), and as a Director of the Berkeley Sensor & Actuator Center (BSAC). Professor Pisano received his B.S., M.S. and Ph.D. (1981) degrees from Columbia University in the City of New York in Mechanical Engineering. Prior to joining the faculty at UC Berkeley, he held research positions with Xerox Palo Alto Research Center, Singer Sewing Machines Corporate R&D Center, and General Motors Research Labs. From 1997-1999, he served as Program Manager for the MEMS program at the Defense Advanced Research Projects Agency (DARPA) in Arlington, VA, where he managed a portfolio of 83 contracts awarded nationwide with a total MEMS research expenditure in excess of $163 million distributed over 3 fiscal years. His research interests and activities at UC Berkeley include MEMS for a wide variety of applications, including RF components, power generation, drug delivery, strain sensors, biosensors and disk-drive actuators. Professor Pisano is co-inventor of over 10 patents in MEMS and has authored or co-authored more than 115 archival journal publications. He is a founder in four start-up companies in the area of transdermal drug delivery, transvascular drug delivery, sensorized catheters and manufacturing equipment.
Claire Pomeroy, M.D., Vice Chancellor for Human Health Sciences, UC Davis, Dean, UC Davis School of Medicine.
Claire Pomeroy is an expert in infectious diseases and a professor of internal medicine and microbiology and immunology. She oversees the UC Davis Health System and all its academic, research and clinical programs, including the 800-member physician group known as UC Davis Medical Group and the 576-bed acute-care hospital known as UC Davis Medical Center. With an operating budget of nearly $800 million, patient visits of nearly 900,000, and more than $100 million in outside research funding, UC Davis Health System is a major contributor to the health care and economy of the Sacramento region.
Dr. Pomeroy joined UC Davis
in 2003 as executive associate dean of the School of Medicine. In that role,
she guided the development of a new strategic plan, enhanced the infrastructure
for research and educational programs, and integrated the operations of the
medical school and teaching hospital. Dr. Pomeroy leads an active research team
studying host responses to infectious diseases. She has published over 100 articles
and book chapters and edited two books. She currently serves on grant review
study sections for the National Institutes of Health and the Department of Veterans
With special expertise in HIV/AIDS, she is a long-time advocate for patients with HIV/AIDS and has a special interest in health-care policy. She also has led efforts to advance electronic health records to improve health-care quality. Dr. Pomeroy is a member of the Board of Directors of the M.I.N.D. Institute at UC Davis and of the CARES clinic in Sacramento. She will be president of the CARES board in 2005.
Dr. Pomeroy is a member
of the recently established Independent Citizens Oversight Commission that will
govern the stem cell research institute approved by California voters in the
Nov. 2 election.
Dr. Pomeroy received bachelor's and medical degrees from the University of Michigan, then completed her residency and fellowship training in internal medicine at the University of Minnesota. She also earned an M.B.A. from the University of Kentucky. She held faculty positions at the University of Minnesota and the University of Kentucky prior to her move to UC Davis. At the University of Kentucky, she served as associate dean for research and informatics and as a member of the University Board of Trustees. She lives in Sacramento with her husband, William Preston Robertson, a filmmaker and author.
Chuck Rzeszutko is a member of Policy, Analysis, and Campus Services (PACS) in the University of California's central Office of Technology Transfer. Among his other activities, Mr. Rzeszutko coordinates the University's equity program and provides expertise in the areas of copyright and the University's intellectual property policies relating to faculty consulting.
Before joining PACS, Mr.
Rzeszutko spent ten years at Los Alamos National Laboratory, where his responsibilities
included licensing team leader in the Laboratory's technology transfer office,
deputy project leader for the development of automated chemical analysis systems
using robotics, and lead for environmental monitoring and assessment activities.
Prior to joining LANL, Mr. Rzeszutko served as a sales representative in Hewlett
Packard's Analytical Instruments group, covering Colorado and New Mexico.
Mr. Rzeszutko received his M.S. and B.S. degrees in Chemistry (Analytical Organic) from DePaul University.
Wendy Streitz is the Director of Policy, Analysis, and Campus Services (PACS) in the University of California's central Office of Technology Transfer. The PACS unit provides coordination for the systemwide technology transfer program, including guidance for campuses and external entities regarding the University's intellectual property policies and practices.
Prior to joining the University
of California, Ms. Streitz was Associate Director, Intellectual Property and
Technology Transfer at Auburn University in Alabama, where her caseload included
technologies from both the physical and life sciences. Prior to that, she spent
twelve years at Westinghouse Electric Corporation, holding leadership positions
in signal processing.
Ms. Streitz received a B.S. Engineering from Harvey Mudd College and an MSEE from Johns Hopkins University.